Wendy Stock to Transfection
This is a "connection" page, showing publications Wendy Stock has written about Transfection.
Connection Strength
0.037
-
Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia. Oncotarget. 2014 Dec 15; 5(23):12371-82.
Score: 0.027
-
Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol. 2001 Feb; 29(2):244-55.
Score: 0.010